Experts allay Covaxin concerns, say 50% effectiveness against Delta-driven Covid surge not bad

The results of the first real-world assessment of Covaxin published in The Lancet Infectious Diseases journalThe results of the first real-world assessment of Covaxin published in The Lancet Infectious Diseases journalNationalRead More